The European Medicines Authority’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for a new drug to treat hereditary angioedema (HAE).
Dr. Neelam A. Phadke: A 54-year-old woman with a history of episodic swelling of the arms, hands, and feet was evaluated in the emergency department of this hospital because of abdominal pain, nausea, ...
Like angioedema in general, hereditary angioedema (HAE) is characterized by subcutaneous or submucosal edema that is nonpruritic — ie, does not itch — and nonpitting — ie, does not leave an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results